Adaptimmune Therapeutics vs Kite Pharma
Adaptimmune Therapeutics vs Kite Pharma, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Adaptimmune Therapeutics is on 44/100 and Kite Pharma on 66/100.
Where each one leads
Adaptimmune Therapeutics
Leads on none of the measures we hold for both companies.
Kite Pharma
- our overall score: 66/100 against 44/100
- domain rating: 62/100 against 52/100
- funding raised: $421M against $107M
At a glance
| Measure | Adaptimmune Therapeutics | Kite Pharma |
|---|---|---|
| What it is | Biopharmaceutical company developing T-cell therapies for solid tumor cancers. | Biotechnology company developing and commercializing cell therapies for cancer treatment. |
| Category | Biotechnology, Pharmaceuticals, Drug Discovery, Cancer Immunotherapy | Biotechnology, Pharmaceuticals, Oncology, Cell Therapy |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Services |
| Founded | 2008 | 2009 |
| Headquarters | Abingdon, United Kingdom | Santa Monica, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | Adaptimmune Therapeutics | Kite Pharma |
|---|---|---|
| Employees | 191 | Not published |
| Total funding | $107M | $421M |
| Latest round | Series A | Venture |
| LinkedIn followers | 54,208 | Not published |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Adaptimmune Therapeutics | Kite Pharma |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 44/100 | 66/100 |
| Traction | 60/100 | 40/100 |
| Team | 30/100 | 80/100 |
| Search visibility | 30/100 | 15/100 |
| Quality | 45/100 | 90/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 52/100 | 62/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Adaptimmune Therapeutics | Kite Pharma |
|---|---|---|
| Hosting | AWS | Not detected |
| CDN | Not detected | Cloudflare |
| Frameworks | Bootstrap | Tailwind CSS, Bootstrap |
| Analytics | Google Analytics 4, Linkedin Insight | Google Tag Manager |
Adaptimmune Therapeutics vs Kite Pharma: common questions
Which is better, Adaptimmune Therapeutics or Kite Pharma?
On our 0-100 score Kite Pharma rates higher (66/100 against 44/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do Adaptimmune Therapeutics and Kite Pharma compare on the numbers?
Kite Pharma leads on our overall score (66/100 against 44/100), domain rating (62/100 against 52/100), funding raised ($421M against $107M).
Read the full Adaptimmune Therapeutics review and pricing or the Kite Pharma review and pricing. You can also browse other Adaptimmune Therapeutics alternatives we track.